We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Clinical evaluation reports ceperognastat activity and safety in Alzheimer disease, indicating therapeutic potential against tau-mediated neurodegeneration.
No takes yet. Share an insight, caveat, or question.
Rabinovici et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: